The guidance withdrawal is the most significant signal, it removes the forward anchor for the stock and implies management sees material downside risk to prior expectations. With cash burning rapidly ($20.4M in H1 2026) and the company still deeply unprofitable, watch for a potential capital raise or restructuring announcement in the coming months. The new CEO's strategic review could lead to asset sales or a reverse merger.
How the stock moved after the report
BEARISH VIEWSTOCK ABOVE ENTRY AT T+60- T+0 · Aug 11 $0.7900entry
- T+1 · 3mo ago −8.84%α −9.09% · $0.7202
- T+5 · 3mo ago −18.61%α −18.20% · $0.6430
- T+20 · 2mo ago +15.35%α +16.41% · $0.9113
- T+60 · 13d ago +6.05%α +6.54% · $0.8378
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
TELA Bio reported Q2 2026 revenue of $19.3M, a 4% decline YoY, and an EPS of -$0.20, missing consensus estimates of -$0.18. The company withdrew its full-year 2026 revenue guidance, citing a decline in OviTex PRS volumes and ongoing price/mix headwinds. A new CEO was appointed, but the guidance withdrawal and revenue miss signal significant near-term uncertainty and deteriorating fundamentals for this $39M market-cap medical device company.
Key Financial Metrics
Key Facts
- Revenue declined 4% YoY to $19.3M, missing consensus of $20.0M
- EPS of -$0.20 missed consensus of -$0.18 (-12.4% miss)
- Full-year 2026 revenue guidance withdrawn, citing OviTex PRS volume decline and competitive bundling pressures
- Net loss widened to $11.3M from $9.9M in the prior-year quarter
- Cash burn continues: cash dropped to $30.4M from $50.8M at year-end 2025
- New CEO Heather Getz appointed August 4, 2026, signaling a strategic review
Financial Impact
Revenue miss of ~$0.7M vs consensus; guidance withdrawal removes forward visibility for a $39M market-cap company
Risk Factors
- Further revenue deterioration in H2 2026 as OviTex PRS headwinds persist
- Cash runway concern: $30.4M at current burn rate (~$11M/quarter) provides ~9 months of liquidity
- Potential dilutive equity offering to extend runway
- Competitive bundling from larger players could continue pressuring market share and pricing
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 6 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001104659-26-093371 |
| Document: tm2622768d1_8k.htm | 0001104659-26-093371 |
| Document: 0001104659-26-093371-index-headers.html | 0001104659-26-093371 |
| Document: 0001104659-26-093371-index.html | 0001104659-26-093371 |
| Document: 0001104659-26-093371.txt | 0001104659-26-093371 |
| 8-K Data (Synthetic) | 0001104659-26-093371 |
Track record
20 reports on TELA
The track record builds as more bullish or bearish reports settle.
Filters
- Nov 16, 2026today SC 13G/A Neutral 3/10 Entry $0.7610 Now $0.7620 +0.13% settles Nov 23
- Nov 13, 20263d ago SC 13G/A Neutral 2/10 Entry $0.8200 Now $0.7620 −7.07% settles Nov 23
- Nov 13, 20263d ago SC 13G/A Neutral 2/10 Entry $0.8201 Now $0.7620 −7.08% settles Nov 23
- Nov 10, 20266d ago S-3 Bearish 5/10 Entry $0.9418 Now $0.7620 +19.09% settles Nov 18
- Nov 10, 20266d ago Press Release Bearish 5/10 Entry $0.9418 Now $0.7620 +19.09% settles Nov 18
- Oct 27, 202620d ago Press Release Neutral 2/10 Entry $0.9760 to $0.8378 Now $0.7620 −21.93% ▼ −14.16% −13.45% vs SPY
- Oct 6, 20265w ago 8-K Neutral 3/10 Entry $1.07 to $1.10 Now $0.7620 −28.79% ▲ +2.34% +3.32% vs SPY
- Oct 5, 20266w ago 8-K Bullish 5/10 Entry $1.14 to $1.08 Now $0.7620 −33.16% ▼ −5.26% −5.69% vs SPY
- Aug 31, 202611w ago 8-K Mixed 6/10 Entry $0.7380 to $0.8301 Now $0.7620 +3.25% ▲ +12.48% +12.62% vs SPY
- Aug 10, 202614w ago 8-K Bearish 7/10 Viewing Entry $0.7900 to $0.6430 Now $0.7620 +3.54% ▲ +18.61% +18.20% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers